Alzheimer’s is not a random strike of bad luck; it is a systems failure. While the specific inputs vary for everyone: genetics, pathogens, diet, or trauma, the mechanical result is always the same: debris accumulates faster than it can be cleared.
Presented here is a symbolic representation of the primary variables. This model is not a calculator, but a way to understand the velocity of decay. It makes visible why treatments that target only one variable are mathematically doomed to fail to work on everyone.
Alzheimer’s occurs when the Pathogenic Entropy (Tau/Amyloid) scales faster than the Governor(GSK3β) prevents it and the Protocol (Estrogen/Choline) can regulate it (via the glymphatic system), exacerbated by an exponential rise in Substrate Friction (Fibrosis) that reduces/prevents waste export.
\(\displaystyle \Psi_{AD} = \int_{0}^{t} \frac{\left[ (\mathbf{K}_{\tau} \otimes \mathbf{K}_{A\beta}) \cdot \mathcal{I}_{NLRP3} \right]}{\left[ \mathcal{G}(Li \cdot GSK3\beta^{-1}) \cdot PRO(ER\alpha \cdot \text{PEMT}) \right] \cdot \Omega_{ATP}} \cdot e^{\left( \frac{\Gamma_{\text{fibrosis}} \cdot \text{PAI-1}}{EPA \cdot \text{Natto}} \right)} \, dt\)
The Complexity Load: Represents the exponential “coupling” of Tau Tangles and Amyloid Plaques.
INLRP3 The Accelerant - Neuroinflammation:
The Concept: Plaques and Tangles are inert trash until the immune system reacts. The NLRP3 Inflammasome is the driver that turns “trash” into “war.” Note this can often be driven by intestinal permeability.
The Mechanic: When Microglia sense Amyloid, they activate NLRP3, releasing Cytokines (IL-1β, TNF-α) killing neurons that might otherwise have survived the plaque load.
The Multiplier: If Entropy is high but Inflammation is zero, the numerator remains manageable (Asymptomatic AD). If Inflammation spikes,ΨAD goes vertical
The Lithium Brake: This is the Governor (G). Lithium inhibits GSK3β, which is the enzyme that “writes” the Tau error. Without Lithium or Estrogen, the Governor fails, and the numerator grows unchecked. Note: If the Numerator is rising due to an active infection (Herpes, Mold, Gum Disease), the body creates Amyloid as an antimicrobial defense. In this case, the Governor isn't failing; it's responding to a threat. This is why removing Amyloid without removing the threat often fails.
The Choline Currency: This is the Signal Fidelity (PRO). ERα (Estrogen) activates the PEMT gene to create Phosphatidylcholine. This process is rate-limited by Methylation (B-Vitamins/Homocysteine). This provides the “Bandwidth” for Acetylcholine. If this term drops (as in menopause or APOE4), the system loses its ability to produce Choline.
The Constraint: Repairing DNA, synthesizing Choline, and exporting waste via the Glymphatic system are all active transport mechanisms. They cost ATP.
The Failure State: In Insulin Resistance (Type 3 Diabetes), neurons cannot uptake glucose. ΩATP approaches zero. As the denominator shrinks, the total equation value (AD Risk) skyrockets.
The Friction Coefficient: This represents the Temporal Cost (T).
Γfibrosis: The perivascular “clogging” that stops waste removal.
EPA & Natto: These are some of the ways that can reduce friction, keeping the exponential decay in check by ensuring the “pipes” remain open for the sleep-based cleanup cycle via reduction of PAI-1. (Note: the clinical data on Nattokinase penetrating the blood-brain barrier and significantly clearing perivascular fibrosis in humans is still emerging)
Every suggested Alzheimer’s prevention strategy comes down to balancing this equation.
Crucially, this model defines the velocity of decay. It is accurate for Prevention (Stage 0–2). However, for Reversal (Stage 3+), simply balancing the equation is necessary but insufficient. Halting the entropic slide stops the progression, but replacing dead neurons requires a separate “Regeneration Equation” (driven by BDNF and Neurogenesis), which is not modeled here.
When we review the vast landscape of suggested Alzheimer's interventions, from cutting-edge pharmaceuticals to lifestyle protocols we find they are all simply an attempt to manipulate one or more of these variables:
Regulate Entropy : Interventions like Lithium Orotate are used to inhibit the error-writing enzyme GSK3β, effectively slowing the hyper-phosphorylation of Tau.
Modulate Input Gain (The Stabilizer): Research into Levetiracetam (Keppra) suggests it works by dampening Hippocampal Hyperexcitability, reducing the "neural noise" that accelerates Amyloid generation.
Reduce Inflammation: Protocols involving Curcumin, Fasting, or Ketosis aim to downregulate the NLRP3 Inflammasome & TNF-α, preventing the immune system from over reacting.
Restore Energy: Strategies like MCT Oil, Ketones, and Insulin Sensitization are designed to maximize Metabolic Capacity (ΩATP), ensuring the brain has the fuel to run its repair systems.
Signal Fidelity (The Protocol): Supplementation with Phosphatidylcholine, Citicoline, and B-Vitamins targets the PEMT pathway, ensuring there is enough raw material to maintain membrane integrity and Acetylcholine levels. Improved Estrogen signaling/HRT and ensure adequate Methylation (B-Complex/Folate) also results in natural creation of Choline.
Waste Export (The Flow): The use of Nattokinase, EPA, and Deep Sleep optimization targets the friction coefficient (fibrosis), attempting to keep the glymphatic pipes clear of fibrin and amyloid debris.
If we look at Alzheimer's treatments through the lens of this equation, we see why they keep missing. They are mathematically incomplete. Brand name (Aduhelm / Leqembi, Aricept, Namenda) only solve part of the equation. Current hope (Namenda, GLP-1, Rapamycin, Viagra) also only solve part of the equation. B-Complex (B6/B9/B12) can improve Choline synthesis and HRT can provide estrogen to produce Choline (as long as metabolism is good to allow for estrogen signaling), but they only change Choline. You cannot solve a multi-variable differential equation by changing just one number.
Appendix:
The most well known genetic connection, the APOE gene e4 variant breakdown
\(\displaystyle D_{Choline} = \sum_{t=0}^{T} \left( \underbrace{\mathcal{R}_{req}(Acetylcholine)}_{\text{Signaling Demand}} - \underbrace{\left[ \Phi(ER\alpha \to \text{PEMT}) \cdot \eta_{APOE} \right]}_{\text{Endogenous Production}} \right) \cdot \underbrace{\left( \frac{1}{Phosphatidylcholine_{synapse}} \right)}_{\text{Structural Decay}}\)
This equation shows that APOE4 carriers aren't just "unlucky"; they are Systemically Solvent only when Estrogen is high. Once ERα drops, the Φ term collapses, and because η is already low, the system enters Insolvency (Alzheimer's) almost immediately. APOE4 carriers have higher choline needs.